Mangalam Drugs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE584F01014
  • NSEID: MANGALAM
  • BSEID: 532637
INR
27.02
0.16 (0.6%)
BSENSE

Aug 07, 03:30 PM

BSE+NSE Vol: 26.44 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 138636,
    "name": "Mangalam Drugs",
    "stock_name": "Mangalam Drugs",
    "full_name": "Mangalam Drugs and Organics Ltd",
    "name_url": "stocks-analysis/mangalam-drugs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "27.02",
    "chg": 0.16,
    "chgp": "0.6%",
    "dir": 1,
    "prev_price": "26.86",
    "mcapval": "44.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532637,
    "symbol": "MANGALAM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE584F01014",
    "curr_date": "Aug 07, 03:30 PM",
    "curr_time": "20:46 PM",
    "last_traded_at": "Aug 07, 03:30 PM IST",
    "bse_nse_vol": "26.44 k",
    "exc_status": "Active",
    "traded_date": "Aug 07, 2026",
    "traded_date_str": "2026 08 07",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/mangalam-drugs-138636-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "When is the next results date for Mangalam Drugs and Organics Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-mangalam-drugs-and-organics-ltd-4140503",
        "imagepath": "",
        "date": "2026-08-06 23:18:53",
        "description": "The next results date for Mangalam Drugs and Organics Ltd is scheduled for 12 August 2026...."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mangalam-drugs-and-organics-ltd-is-rated-strong-sell-4125758",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MangalamDrugsan_mojoScore_4125758.png",
        "date": "2026-07-29 10:10:57",
        "description": "Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 May 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 29 July 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mangalam-drugs-and-organics-ltd-is-rated-strong-sell-4103683",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MangalamDrugsan_mojoScore_4103683.png",
        "date": "2026-07-15 10:11:02",
        "description": "Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 May 2025. However, the analysis and financial metrics discussed below reflect the company’s current position as of 15 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and overall outlook."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Locks at Upper Circuit With 2.84% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-upper-circuit-amid-strong-buying-pressure-4103464",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MangalamDrugsan_stocks_hitting_upper_circuit_4103464.png",
        "date": "2026-07-15 10:00:07",
        "description": "At Rs 28.79, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Mangalam Drugs and Organics Ltd locked at its upper circuit of 2.84% on 15 Jul 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Locks at Upper Circuit With 3.38% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-upper-circuit-amid-strong-buying-pressure-4095403",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MangalamDrugsan_stocks_hitting_upper_circuit_4095403.png",
        "date": "2026-07-09 15:00:07",
        "description": "At Rs 28.27, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Mangalam Drugs and Organics Ltd locked at its upper circuit of 3.38% on 9 Jul 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mangalam-drugs-and-organics-ltd-is-rated-strong-sell-4081522",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/MangalamDrugsan_mojoScore_4081522.png",
        "date": "2026-07-01 10:10:43",
        "description": "Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 May 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 01 July 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mangalam-drugs-and-organics-ltd-is-rated-strong-sell-4061048",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MangalamDrugsan_mojoScore_4061048.png",
        "date": "2026-06-18 10:10:34",
        "description": "Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 18 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd Locks at Upper Circuit With 1.88% Gain — Buyers Queue, Sellers Absent",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/mangalam-drugs-and-organics-ltd-hits-upper-circuit-amid-strong-buying-pressure-4054374",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MangalamDrugsan_stocks_hitting_upper_circuit_4054374.png",
        "date": "2026-06-15 11:00:06",
        "description": "At Rs 29.58, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Mangalam Drugs and Organics Ltd locked at its upper circuit of 5% on 15 Jun 2026, with buyers queuing and no sellers willing to part with shares."
      },
      {
        "title": "Mangalam Drugs and Organics Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/mangalam-drugs-and-organics-ltd-is-rated-strong-sell-4037405",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/MangalamDrugsan_mojoScore_4037405.png",
        "date": "2026-06-05 10:10:20",
        "description": "Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 19 May 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 08 June 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall market standing."
      }
    ],
    "total": 205,
    "sid": "138636",
    "stock_news_url": "https://www.marketsmojo.com/news/mangalam-drugs-and-organics-138636"
  },
  "announcements": [
    {
      "caption": "Intimation Of Resignation Tendered By Ragini Chokshi & Co. Secretarial Auditor Of The Company W.E.F. 4Th August 2026.",
      "datetime": "06-Aug-2026",
      "details": "Intimation pursuant to Regulation 30 read with Schedule III of SEBI (LODR) Regulations 2015 regarding resiagntion tendered by Ragini Chokshi & Co. Secretarial Auditor of the Company w..e.f. 4th August 2026.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On August 12Th 2026 Inter Alia To Approve Un-Audited Financial Results(Standalone & Consolidated) Alongwith Limited Review Report For The Quarter Ended 30Th June 2026.",
      "datetime": "05-Aug-2026",
      "details": "Mangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Prior Intimation as per Regulation 29 of SEBI(LODR) Regulations 2015 of Board meeting to be held on August 12th 2026 inter alia to approve un-audited Financial Results(Standalone & Consolidated) alongwith limited review report for the quarter ended 30th June 2026.",
      "source": "BSE"
    },
    {
      "caption": "Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure",
      "datetime": "16-Jul-2026",
      "details": "Intimation of subsequent default under Para A sub-paragraph 6 of Schedule III",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "12 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Mangalam Drugs and Organics Ltd has declared <strong>5%</strong> dividend, ex-date: 21 Dec 17",
          "dt": "2017-12-21",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock newsNews and Views
stock-recommendationAnnouncement

Intimation Of Resignation Tendered By Ragini Chokshi & Co. Secretarial Auditor Of The Company W.E.F. 4Th August 2026.

06-Aug-2026 | Source : BSE

Intimation pursuant to Regulation 30 read with Schedule III of SEBI (LODR) Regulations 2015 regarding resiagntion tendered by Ragini Chokshi & Co. Secretarial Auditor of the Company w..e.f. 4th August 2026.

Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On August 12Th 2026 Inter Alia To Approve Un-Audited Financial Results(Standalone & Consolidated) Alongwith Limited Review Report For The Quarter Ended 30Th June 2026.

05-Aug-2026 | Source : BSE

Mangalam Drugs & Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve Prior Intimation as per Regulation 29 of SEBI(LODR) Regulations 2015 of Board meeting to be held on August 12th 2026 inter alia to approve un-audited Financial Results(Standalone & Consolidated) alongwith limited review report for the quarter ended 30th June 2026.

Defaults under Para A sub-paragraph 6 of Schedule III-Subsequent Disclosure

16-Jul-2026 | Source : BSE

Intimation of subsequent default under Para A sub-paragraph 6 of Schedule III

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

12 Aug 2026

stock-summary
DIVIDEND

Mangalam Drugs and Organics Ltd has declared 5% dividend, ex-date: 21 Dec 17

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available